The Three Rs for Pharma Commercial Strategies In the pharmaceutical industry, a slew of interesting patterns and relationships have been identified as a result of COVID-19. When it comes to commercial organizations, it’s important that senior sales leaders stay on top of both internal and external trends in order to maintain a competitive edge and […]
MSLs Driving the Strategy Towards P&T Committees In pharma, there is a consistent trend we keep hearing that MSLs are experiencing a role shift in terms of their responsibilities and which key stakeholders they engage with. With organized planning and the right data capabilities, MSLs are better positioned for driving the strategy towards P&T committees […]
Three Key Considerations for Commercial and Market Access Teams Silos. We’ve all heard of this term in the pharmaceutical industry however, do most of us truly understand how negatively silos affect internal and external collaboration? Long-term, consistent, inefficient collaboration can seriously impact an organization’s bottom line. Especially when it comes to the commercialization process, collaboration […]
The Formulary Speaks for Itself, or Does It? There are many factors that need to be taken into consideration when optimizing and accelerating market access. One of the first items that should be on your checklist is honing in on a strong messaging and engagement strategy when targeting payers. In understanding what messaging most resonates […]
Meaningful Data for Meaningful Remote Engagements The digital transformation is changing the way pharmaceutical companies interact with healthcare professionals (HCPs). Life sciences decision-makers need to equip their teams with powerful data to help them best capitalize on HCP communication preferences as well as their geographic, therapeutic area, specialty, and patient mix. With email automation and […]
Keep Your Data Close and Your KOLs Closer It is no question that the COVID-19 pandemic has made in-person engagement much more difficult. As a result, organizations are struggling to maintain relationships with key stakeholders. For pharmaceutical and medical device organizations, medical affairs and sales teams are grounded, making strong targeting and engagement strategies even […]
IDNs Influenced by the B2B Strategy Integrated Delivery Networks (IDNs) are modifying their business strategies due to changes in the industry, such as healthcare reform and financial pressures. IDNs influenced by the B2B strategy are shifting their operating models and changing the way pharmaceutical and medical device companies interact with them. It is also […]
Data Change Management (DCM) Initiatives for Diverse Healthcare Networks Across the life sciences industry, there is a call to break down the silos associated with frequent acquisitions and divestments. Companies are growing faster than they can consolidate their technologies and information, requiring more cohesive digital strategies. With the rise of digital and the number of […]
Life Sciences & Contracts Management: Visibility, Time Savings, & Driving Revenue Value-based contracts (VBCs) are increasing in popularity throughout field, market access, and contracts teams across the life sciences industry. It’s important that relevant data is used to create these types of contracts so that the output is most advantageous to the customer, as well […]
When work gets busy, we tend to let a lot of things fall to the back burner. During visits and meetings, it is still important to prioritize your own health. In doing so, you are keeping yourself and others from getting sick. To avoid the flu, common cold and other pesky illnesses, consider basic tips […]
PharmaTimes: News RSS
English
Arabic
Chinese (Simplified)
Dutch
English
French
German
Italian
Portuguese
Russian
Spanish